LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 (2017)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; FERREIRA, RITA DE CASSIA CAFE - ICB
- Unidade: ICB
- DOI: 10.1016/j.vaccine.2017.11.007
- Subjects: STREPTOCOCCUS MUTANS; ANTICORPOS MONOCLONAIS; ADJUVANTES IMUNOLÓGICOS; PEPTÍDEOS; CAMUNDONGOS; IMUNOGENICIDADE DA VACINA; EPITOPOS; VACINAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BATISTA, Milene Tavares et al. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, v. 35, n. 52, p. 7273-7282, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2017.11.007. Acesso em: 10 fev. 2026. -
APA
Batista, M. T., Ferreira, E. L., Pereira, G. de S., Stafford, P., Maeda, D. L. N. F., Rodrigues, J. F., et al. (2017). LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1. Vaccine, 35( 52), 7273-7282. doi:10.1016/j.vaccine.2017.11.007 -
NLM
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007 -
Vancouver
Batista MT, Ferreira EL, Pereira G de S, Stafford P, Maeda DLNF, Rodrigues JF, Brady LJ, Johnston SA, Ferreira LC de S, Ferreira R de CC. LT adjuvant modulates epitope specificity and improves the efficacy of murine antibodies elicited by sublingual vaccination with the N-terminal domain of Streptococcus mutans P1 [Internet]. Vaccine. 2017 ; 35( 52): 7273-7282.[citado 2026 fev. 10 ] Available from: https://doi.org/10.1016/j.vaccine.2017.11.007 - Bacillus subtilis expression vectors capable of expressing heterologous proteins at different cellular compartments
- Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors
- Bacillus subtilis endospores at high purity and recovery yields: optimization of growth conditions and purification method
- Environmental and genetic factors affecting mutability to aminoglycoside antibiotics among Escherichia coli K12 strains
- Immune modulatory effects of the Mycobacterium bovis GroEL2 expressed by genetically modified Baccillus subtilis strains employed as delivery vectors of vaccine antigens
- The xanthomonas axonopodis citri PHO regulon
- Conservancy and genetic diversity of the oligopeptide permease of pathogenic bacterial species inhabiting the human gastrointestinal tract
- Construção de um novo sistema de expressão e purificação de proteínas recombinantes baseada em esporos de Bacillus subtilis
- Generation of specific polyamine uptake knockout mutans of Streptococcus mutans UA159 strain
- Antibody Responses Elicited In Mice Immunized With Bacillus Subtilis Vaccine Strains Expressing STX2B Subunit of Enterohaemorragic Escherichia Coli O157:H7
Informações sobre o DOI: 10.1016/j.vaccine.2017.11.007 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
